Artificial intelligence is transforming healthcare — from diagnostic imaging and clinical decision support to predictive analytics and personalized treatment. At the same time, regulatory frameworks are rapidly evolving to ensure that these technologies are safe, reliable, and trustworthy.
With the introduction of the EU Artificial Intelligence Act (AI Act) alongside the existing EU Medical Device Regulation (MDR), manufacturers, regulators, and notified bodies face a new challenge: how to translate innovation into compliant medical products.
This webinar explores how AI-enabled medical devices move from technological innovation to regulatory acceptance, focusing on risk management, clinical evidence, and post-market monitoring.